Alana McNulty

Alana B. McNulty is currently an Independent Director at Janux Therapeutics, Inc. since 2021, a Director at Lipidio Pharmaceuticals, Inc. since 2023, and Chief Business Officer at eFFECTOR Therapeutics Operations, Inc. since 2021.
Former roles include Independent Director at NKGen Biotech, Inc. from 2023 to 2024, General Manager & Head-Corporate Development at Advanced Tissue Sciences, Inc. from 1991 to 1998, Associate-BioSciences Group at The Bear Stearns Cos., Inc., Chief Financial Officer & Vice President-Finance at Elitra Pharmaceuticals, Inc. from 1998 to 2003, Chief Financial Officer & Vice President-Finance at BrainCells, Inc. from 2004 to 2011, Chief Financial Officer at Lumena Pharmaceuticals, Inc. from 2012 to 2014, Chief Financial Officer at Excaliard Pharmaceuticals, Inc. in 2011, and Chief Business Officer at eFFECTOR Therapeutics, Inc. from 2020 to 2022.
Education includes undergraduate studies at the University of California, Santa Barbara and an MBA from UCLA Anderson School of Management.